hers semaglutide results Woman shares what happened after she stopped taking ✨ 3 Month Progress ✨
Description
The study period of December 2017 to December 2021 was chosen because semaglutide was approved as Ozempic to treat T2DM in December 2017, and the ending date of December 2021 allowed for a 3-year follow-up for all patients at the time of data collection and analysis on January 6, 2025
The 12mg dose produced the headline results: 24.2% mean body weight reduction at 48 weeks
Considerations for Ozempic Type 2 diabetes : A top choice for those with T2D, offering both blood sugar control and weight loss
Menopause status was defined as women 40 years who had 12 months of amenorrhea not related to other causes (eg, use of contraceptives) or women with a history of bilateral oophorectomy
How much weight can patients expect to lose over a month with Ozempic
